From One Child’s Dark Days with Severe Eczema to a Worldwide Movement

By Giving List Staff   |   November 4, 2024

When Korey Capozza’s son was born in 2008, he was healthy in every way. But nine months later, he began to develop a rash that got progressively worse. By the time he was two, it covered his body from head to toe. He couldn’t sleep. He couldn’t play or go to daycare. He was so itchy that he would scratch until his skin bled.

“The nights were long and the days an agony,” Capozza said. “We struggled to get the eczema under control with the treatments he was getting from his doctor.” They bounced from specialist to specialist, desperately looking for solutions, until finally they went out-of-state to a hospital with a specialized program for severe eczema. 

Living with eczema can be tough, especially for little ones. At Global Parents for Eczema Research, they support families and advocate for better treatments and care. Together, we can make a difference for kids facing moderate to severe eczema.

This journey is typical of those who experience severe eczema. Unlike the more mild form of the disorder, it’s hard to control, involves the entire immune system, and can destroy a child’s quality of life.

Once her son found relief, Capozza, who holds a Master’s in Public Health from the University of California, Berkeley, created a nonprofit, called Global Parents for Eczema Research (GPER), to help other families like hers. GPER navigates the maze of diagnoses and treatment, and advocates for research and policy changes to advance evidence-based care approaches.

Since its launch in 2015, GPER has grown in scope and members, but it remains a grassroots organization with just seven people working to support families besieged by severe eczema. Their Support for Eczema Caregivers (SEC) program is a “lifeline” for parents. Parent coaches work with other families in small groups to help them deal with the often overwhelming skin care routines and cope with the grief and anxiety that can come up. 

The program now reaches over 2,000 families worldwide. GPER also offers a free app for the program and a web-based hub for caregivers featuring a set of holistic resources, from meditations to tools related to cognitive behavioral therapy and stress reduction. 

Their annual Big Ideas Contest invites patients and caregivers to submit their ideas for research with the chance to earn monetary prizes and potential research partnerships or funding for their ideas. The driving notion behind the program is that families have insights that could lead to better treatments or a cure but their knowledge is currently ignored.

Because making sense of therapy and treatment options is increasingly confusing for parents, GPER guides parents through treatment decisions with its online navigator developed using clinical trial data and is presented in a parent-friendly format. “Most parents don’t have the background – or the time – to read dense, scientific articles about eczema treatments. 

“Our podcast and navigator programs do the heavy lifting for them by breaking down the research in an easy-to-understand way,” says Capozza.

Capozza’s son is now 15 and thriving. With more treatments available for children, GPER is now focusing its research grants program on finding a cure for eczema and investing in science that will uncover the causes of the condition.

“We have to find answers because millions of children still suffer from eczema – and more babies are born with it every day,” says Capozza. “My son was the inspiration to start GPER back in 2015, but now, it’s really about the other families,” she says. “So many of them are still in the thick of it, and as someone who has been there, I’m passionate about changing their trajectory.”

 

Global Parents for Eczema Research

Donate now!

www.gper.org
Executive Director: Korey Capozza
(805) 232-4479

Mission

To end suffering of children with eczema through breakthroughs in research and family support.

Begin to Build a Relationship

We know you care about where your money goes and how it is used. Connect with this organization’s leadership in order to begin to build this important relationship. Your email will be sent directly to this organization’s director of development and/or Executive Director.

I became affiliated with GPER as a parent caregiver to a child suffering with eczema. As an academic psychologist I was not only looking for support, but for evidence-based information. I did not want more recommendations of some lotion to buy and try, instead I wanted to communicate with parents who were likeminded. GPER was exactly what I was looking for: a nonprofit that was not only advocating for better research but openly sharing valuable information with caregivers in need!
Angela Tiru,
Caregiver and GPER Board Member

Finding a Cure for Childhood Eczema by 2030

Global Parents for Eczema Research hopes to raise $100,000 this year to double their research program in 2025 and accelerate their progress towards a cure by 2030, which is the vision of their organization. 

They are funding research in three specific areas which show the most promise in preventing eczema in babies: 

    •Interventions to improve the gut microbiome

    •Strategies to improve the skin barrier

    •Ways to avoid environmental exposures that increase the risk for eczema in children

Your donations will help fund research that gets us closer to a world where no child has to suffer from childhood eczema.

Key Supporters

Board Members:
Dr. Jeff Mcbride, Board President:
Dermatologist, University of
Oklahoma, USA
Santanna Hernandez, Board
Secretary/Treasurer: Mother
of four children with eczema
and medical student, Canada
Dr. Ian Myles, Board Member: Head
of the Epithelial Therapeutics Unit
at the National Institute of Allergy
and Infectious Diseases, NIH, USA
Dr. Peck Ong, Board Member:
Pediatric Immunologist, University
of Southern California and
Children’s Hospital Los Angeles, USA
Angela Tiru, Board Member:
Professor of Psychology and
Eczema Parent, USA
Corporate Sponsors:
Galderma
Incyte
Sanofi
Amgen
Kyowa Kirin
Regeneron
Lilly
Leo
Astria
Dermavant
Pfizer
Pierre Fabre
Smart and Final